GLIPIZIDE

Glipizide is a sulfonylurea that lowers blood glucose by stimulating betacell insulin release. Side effects include hypoglycemia, headache, and GI discomfort. Only GMP materials will be supplied, logistics all according to GDP.

SKU: e791f5ee65dc Category: Tag:

Product Description


Mechanism of Action

Glipizide is a sulfonylurea that binds SUR1 on pancreatic K⁺ATP channels, enhancing insulin secretion from beta cells and improving glucose control.

Benefits and Advantages

Used in pancreatic-islet research, insulin-secretion modelling, metabolic studies and endocrine pharmacology.

Side Effects and Risks

Hypoglycemia, weight gain and rare cholestatic reactions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C21H27N5O4S

Molecular Weight

445.5 g/mol

CAS Number

29094-61-9

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

glipizide; 29094-61-9; Glucotrol; Glydiazinamide; Glibenese

IUPAC/Chemical Name

N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide

InChl Key

ZJJXGWJIGJFDTL-UHFFFAOYSA-N

InChl Code

InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)

References

https://pubchem.ncbi.nlm.nih.gov/compound/3478;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download